The SRI is frequently used to measure quality of life in severe COPD patients treated with NIV, but its MCID is unknown. This paper shows MCID estimates between 4.5–6.2, so that we suggest an increase of approximately 5 points is clinically relevant.https://bit.ly/3e0M7MT